Humans have been attempting to combat cancer since the time of the Ancient Egyptians, and recent decades have seen remarkable progress. However, tumor cells have developed sophisticated ways to evade ...

General practitioner examining a patient's hand for signs of rheumatoid arthritis. A breakthrough in cancer and autoimmune disease therapy could unlock a whole new frontier in medicine. Scientists are ...

One of the best ways to defeat cancer is by rousing the immune system to attack it. Experts have thought that immune cells had to be inside of tumors for one type of immunotherapy, known as checkpoint ...

Checkpoint inhibitors are a groundbreaking class of cancer treatment, but they come with two frustrating challenges. In some cases, tumors show no initial response, rendering the therapy ineffective ...

A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive immune checkpoint inhibitor treatments for colorectal cancer in the U.S. The ...

WASHINGTON — Immune checkpoint inhibitor (ICI) therapy does not increase mortality in people with preexisting autoimmune diseases, new research has found. Results from a large database analysis of ...

Dr. Luc Morris, a surgeon and research lab director at MSK, was the co-senior author of a research study to predict who will benefit from immune checkpoint inhibitors, a type of immunotherapy, using ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature ...

Please provide your email address to receive an email when new articles are posted on . Black and Hispanic patients continue to be underrepresented in immune checkpoint inhibitor trials. Almost ...

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

A potent bacterium in the human gut can supercharge the effects of some cancer drugs in mice — and researchers are now planning a clinical trial to test whether it could do the same in people. The ...